Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up

Xeroderma pigmentosum group C

MONDO:0010211

An autosomal recessive inherited disorder caused by mutations in the XPC gene. This disease is characterized by increased sensitivity to sunlight with the development of carcinomas at an early age and is caused by a defect in nucleotide excision repair.

Also known as: XP-C, XP3, XPC, XPCC, xeroderma pigmentosum group C, xeroderma pigmentosum group type C, xeroderma pigmentosum, complementation group type C, xeroderma pigmentosum, group C

3 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Disease (680) Metabolic disease (233) Hereditary disease (176) Skin disorder (132) Inborn errors of metabolism (45) Human disease (14) DNA repair disease (13) Hereditary skin disorder (6) Xeroderma pigmentosum (4) Disease of genetic or genomic mechanism (2)
Trials to join now! 1 Not yet finished but already full! 1 Completed 1
Sort by
  • New drug combo targets Hard-to-Treat cancers in early trial

    Disease control Recruiting now

    This study tests a new drug called AZD4956, alone or with other cancer drugs, in people with advanced or spreading solid tumors that have a specific DNA repair defect (HRR deficiency). The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. …

    Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control

    Last updated Aug 13, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space